Steve Cohen: DEA opens U.S. hearing on reclassifying marijuana as Schedule III drug

Steve Cohen: DEA opens U.S. hearing on reclassifying marijuana as Schedule III drug
DEA reviews U.S. marijuana rules

The U.S. Drug Enforcement Administration has commenced an administrative hearing regarding its proposed reclassification of marijuana as a Schedule III substance under the Controlled Substances Act. The development, noted by commentator Steve Cohen, comes in recognition of marijuana's therapeutic potential. However, Cohen draws attention to the fact that criminal penalties and mandatory minimum sentences related to marijuana would remain unchanged, even if the DEA proceeds with the rule change.

Cohen previously commented on significant U.S. policy developments, including the Supreme Court's decision to uphold birthright citizenship. He also addressed concerns about the impact of presidential involvement in World Cup rulings on the U.S. international image. These observations follow his ongoing focus on the legal and regulatory actions shaping national policy.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.